Widely Prescribed Stimulants and the Risk of Psychosis in Young People with ADHD
Each month The Brain & Behavior Research Foundation hosts a Meet the Scientist Webinar featuring a researcher discussing the latest findings related to mental illness. In July, 2020, the Foundation featured Dr. Lauren Moran of Harvard Medical School.
Description: The prescription use of stimulants such as Ritalin and Adderall (methylphenidate and amphetamine, respectively) for the treatment of ADHD has been increasing. In 2007, the FDA mandated changes to drug labels for stimulants, based on findings about increased risk for psychosis. We studied whether the risk of psychosis in patients with ADHD differs among various stimulant types and found that patients prescribed amphetamine were at a higher risk of new psychosis requiring treatment with antipsychotic medicines than patients who had been prescribed methylphenidate.
Learn more at https://www.bbrfoundation.org/event/widely-prescribed-stimulants-and-risk-psychosis-young-people-adhd
Visit us on the web: https://www.bbrfoundation.org If you like this presentation, please share it!